Tenofovir Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, & Pharmacodynamics (DREAM 01)

By sjmartinez • November 30, 2023

Weld ED, McGowan I, Anton P, Fuchs EJ, Ho K, Carballo-Dieguez A, Rohan LC, Giguere R, Brand R, Edick S, Bakshi RP, Parsons T, Manohar M, Seigel A, Engstrom J, Elliott J, Jacobson C, Bagia C, Wang L, Al-Khouja A, Hartman DJ, Bumpus NN, Spiegel HML, Marzinke MA, Hendrix CW. Tenofovir Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, & Pharmacodynamics (DREAM 01). J Infect Dis. 2023 Nov 29:jiad535. doi: 10.1093/infdis/jiad535. Epub ahead of print. PMID: 38019657.

Tags: Digestive Diseases, HIV, Infectious Diseases, Microbicide, Pharmacodynamics, Pharmacokinetics, phase I, Pre-exposure prophylaxis, Publications

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across Racial and Ethnic Groups

Patel C, Abboud Y, Karkra R, Qureshi I, Gaglio P, Lingiah V, Al-Khazraji A, Hajifathalian K. Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across[...]

Reducing demographic bias in biomedical machine learning for cancer detection using cfDNA methylation

Li S, Zeng W, Li W, Liu CC, Zhou Y, Ni X, Stackpole ML, Yeh AH, Melehy A, Lu DS, Raman SS, Hsu W, Mishra[...]